This is a free preview for the upcoming Stealth Therapeutics.
Company: Stealth BioTherapeutics Inc.
Symbol: MITO
Description: They are a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction.
Shares: 6.2 million ADSs
Price Range: $12.00-$14.00
Trade Date: 2/15
Underwriter(s): Jefferies, Evercore, BMO Capital
Co-Manager(s): Nomura
Terms Added: 2-6-19
Business :Mitochondria, found in nearly every cell in the body, are the body’s main source of energy production and are critical for normal organ function. Dysfunctional mitochondria characterize a number of rare genetic diseases, collectively known as primary mitochondrial diseases, and are also involved in many common age-related diseases. They believe their lead product candidate, elamipretide, has the potential to treat both rare genetic and common age-related mitochondrial diseases.
Indications of Interest: Their existing principal shareholder, Morningside Venture (I) Investments Limited, certain entities associated with it, certain of the holders of our outstanding convertible notes and entities associated with such holders have indicated an interest in purchasing up to an aggregate of approximately $60.0 million of ADSs in this offering at the initial public offering price and on the same terms as the other purchasers in this offering.
IPO Boutiuqe Color, Commentary & Book-Building Status: The way the book comes together during the week of the roadshow is the most critical indicator to first-day and first-week performance. IPO Boutique uses its 45 years of experience and sources all over the street to gather daily subscription levels, specific price guidance and what type of investors are currently in the book or are anchoring orders in the book. In addition, recent underwriter performance on sector specific deals is a strong factor that IPO Boutique takes into account when determining if our clients should indicate for any offering.
IPO Boutique subscription clients receive daily updates on this critical information.
Conclusion: IPO Boutique provides ratings, daily commentary and a forecast for how this IPO will open vs. its offering price. We have kept a track record with our performance for last 12 years at our website. Additionally, here’s a 2017 recap of our performance to showcase the value of IPO Boutique’s service.
Indicate with confidence, SUBSCRIBE today.
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish